Karen G. Hirsch, MD

Neurocritical care specialist

Assistant Professor of Neurology and, by courtesy, of Neurosurgery at the Stanford University Medical Center

Stroke Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6469
Learn More About the Clinic Getting Here Make An Appointment

Neurocritical Care Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 866-742-4811
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Internship: Stanford University Hospital -Clinical Excellence Research Center (2007) CA

Fellowship: University of California San Francisco (2012) CA

Board Certification: Neurology, American Board of Psychiatry and Neurology (2010)

Residency: Johns Hopkins University (2010) MD

Medical Education: Stanford University (2012) CA

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

An Update on Neurocritical Care for the Patient With Kidney Disease
Hirsch, K. G., & Josephson, S. A. (2013). An Update on Neurocritical Care for the Patient With Kidney Disease. ADVANCES IN CHRONIC KIDNEY DISEASE, 20(1), 39-44.

Treatment of Elevated Intracranial Pressure with Hyperosmolar Therapy in Patients with Renal Failure
Hirsch, K. G., Spock, T., Koenig, M. A., & Geocadin, R. G. (2012). Treatment of Elevated Intracranial Pressure with Hyperosmolar Therapy in Patients with Renal Failure. NEUROCRITICAL CARE, 17(3), 388-394.

Boomerang Sign on MRI
Hirsch, K. G., & Hoesch, R. E. (2012). Boomerang Sign on MRI. NEUROCRITICAL CARE, 16(3), 450-451.

Cerebral blood flow and cerebrovascular autoregulation in a swine model of pediatric cardiac arrest and hypothermia
Lee, J. K., Brady, K. M., Mytar, J. O., Kibler, K. K., Carter, E. L., & Koehler, R. C. (2011). Cerebral blood flow and cerebrovascular autoregulation in a swine model of pediatric cardiac arrest and hypothermia. CRITICAL CARE MEDICINE, 39(10), 2337-2345.

Clinical and Radiographic Natural History of Cervical Artery Dissections
Schwartz, N. E., Vertinsky, A. T., Hirsch, K. G., & Albers, G. W. (2009). Clinical and Radiographic Natural History of Cervical Artery Dissections. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 18(6), 416-423.

Occurrence of Perimesencephalic Subarachnoid Hemorrhage During Pregnancy
Hirsch, K. G., Froehler, M. T., Huang, J., & Ziai, W. C. (2009). Occurrence of Perimesencephalic Subarachnoid Hemorrhage During Pregnancy. NEUROCRITICAL CARE, 10(3), 339-343.

Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition
Rahmani, M., Yu, C. R., Reese, E., Ahmed, W., Hirsch, K., & Grant, S. (2003). Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. ONCOGENE, 22(40), 6231-6242.

The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells
Cartee, L., Wang, Z. L., Decker, R. H., Chellappan, S. P., Fusaro, G., & Grant, S. (2001). The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. CANCER RESEARCH, 61(6), 2583-2591.